Pause for station identification

aut-viam-inveniam-aut-faciam
“I will find a way or make one” – on my Harvard University chair kindly given by Gary Silverman on my departure from his lab

A year and half has gone by since my last station identification. So I thought it might be a good time for me to update things.

Me
Hello. My name is Charlie Schick. I’m passionate about the intersection of healthcare, mobile, and data; particularly how we can improve the way healthcare organizations engage with customers, patients, and families. I also advise companies on digital transformation, solutions design, and content marketing.

I enjoy solving difficult and complex problems through insights, action, and innovative digital solutions. And I have over 25 years experience crafting and applying digital strategies to drive success in marketing, sales, solution design and development, and research. In this time, I have been influential leading major brands, such as IBM, Nokia, and Boston Children’s Hospital, with innovative ways of engaging with customers through digital solutions.

777labs
I make this experience available to clients through 777labs, an innovation and strategy consultancy helping clients identify, craft, and deliver digital solutions that grow their business and engage with their customers. We combine our experience in digital transformation and solution design with our analytical research and consumer insight to guide and help clients think strategically about their digital business. Through product, market, and customer research; innovation strategy design and execution; and commercialization, product adoption, and customer engagement strategy and execution we help clients solve key business issues and be more innovative, agile, and customer centric. [Yes, that’s the pitch.]

Innovations in Addiction and Mental Illness
I also lead a multi-disciplinary community of Boston-area innovators evaluating and addressing opioid use from a fresh and broad perspective. My intent is to connect stakeholders; reframe the problem; and identify, craft, and deploy innovative solutions addressing opioid use.

Our goal is to build a resilient addiction and mental illness system. A viable ecosystem to not only address opioid use, but also addiction in general, psychoergonomics, neurodiversity, suicide, and mental illness.

Thinking and speaking and helping
Beyond the consultancy and ISAMI, I continue giving talks and running panels. I regularly speak in front of large audiences, sharing my experience and interests through various forms of media and design, and in the office of CxOs. Send me a note if you want to know more.

And of course, my standard disclaimer
(riffing off of an ancient Cringely disclaimer)
Everything I write here on this site is an expression of my own opinions, NOT of any of my clients. If these were the opinions of my clients, the site would be called ‘777labs’ client’s something or other’ and, for sure, the writing and design would be much more professional. Likewise, I am an intensely trained professional writer :-P, so don’t expect to find any confidential secret corporate mumbo-jumbo being revealed here.

If you have ideas or projects that you think I might be interested in please contact me, Charlie Schick, at firstname.lastname@molecularist.com; via my profile on LinkedIn; or via @molecularist on Twitter. And if you’re interested in working with 777labs, you can contact me at firstname.lastname@777labs.co.